Marco's Morning Report — Saturday, August 29, 2026

Morning, Marco. One clinical correction worth your coffee: the cyclospora outbreak you've been tracking since July did not close its exposure window — CDC's Thursday revision pushed the last symptom onset out to August 15 and added three states. If you filed "lettuce question" under settled, unfile it. Also this morning: CDC and Pennsylvania are publicly fighting over whether two measles deaths were measles deaths, a half-billion-dollar risk-coding settlement landed 100 miles up I-75, and the debate is over whether the surprise-billing arbitration system is a fix or a faucet. Then sleep.

A · Top Stories

Update · Outbreak

Cyclospora outbreak didn't close — onsets now run through August 15, three new states added

CDC's August 27 revision puts the Taylor Farms de México iceberg lettuce outbreak at 11,458 laboratory-confirmed illnesses across 20 states, at least 495 hospitalizations and two deaths (both Michigan). Georgia, Tennessee and Texas were added since the August 20 update. The number that matters more than the case count: illness onsets now extend to August 15. Earlier CDC pages had the last onset at July 31, then August 3, then August 11 — each revision has moved it forward.

Why it matters to you: the "recall closed the window" framing you'd have reasonably taken from the earlier updates is wrong. Onsets four weeks after the July 17 recall, on a six-week confirmation lag, means an 80-year-old admitted next week with two weeks of watery diarrhea, anorexia and 8 lb of weight loss is still in scope. Cyclospora doesn't show on a routine O&P and isn't on every multiplex GI panel — it has to be asked for by name, and TMP-SMX is the only real answer, which makes the sulfa-allergy patient a decision you want made before 3 a.m., not during.

Action: keep the lettuce question in the summer diarrheal H&P rather than retiring it, and confirm with your lab whether the GI panel reports Cyclospora or whether modified acid-fast has to be ordered separately.

Public Health · Federal-State

CDC publicly disputes Pennsylvania's two measles deaths

CDC posted on social media that Governor Josh Shapiro has declined federal assistance and withheld detail on the two Lancaster County deaths reported August 25 — the first US measles deaths of 2026, one of them an infant — and credited HHS Secretary Robert F. Kennedy Jr. for raising questions about whether the patients died of measles. Pennsylvania's health department called that characterization inaccurate, said it shares data with CDC program staff regularly, and clarified that its own term, "measles-associated death," means laboratory or epidemiologic evidence of measles was present without the certifier necessarily naming measles as the immediate cause. Bloomberg · CNN

Why it matters to you: this is a fight about death certification, which is a document you sign. The distinction Pennsylvania is drawing — associated vs. caused — is the same one you make on every elderly septic patient with four comorbidities, and it is now a nationally contested political object. Expect families to arrive already primed to ask whether a listed cause of death is "real."

Talking point: worth a two-minute conversation with whoever handles your death certificates about how immediate cause vs. contributing conditions get documented, before anyone from outside the hospital asks.

Florida · Enforcement

The Villages Health to pay $541.5M over Medicare Advantage diagnosis coding

DOJ announced on August 27 that The Villages Health System — the Central Florida primary care network Humana bought for $68M late last year — will pay $541.5M to resolve False Claims Act allegations that from 2020 to 2024 it submitted unsupported diagnosis codes to Humana, UnitedHealthcare and GuideWell to raise Medicare Advantage risk-adjusted payments. The company self-disclosed through the HHS-OIG protocol in December 2024; the bankruptcy court approved the settlement this week. Healthcare Dive

Why it matters to you: Southwest Florida is about as MA-dense as the country gets, and half a billion dollars against a self-disclosing primary care group sets the going rate. Enforcement attention on risk-adjustment coding doesn't stay in the outpatient chart — the diagnoses you document on an admission (acute-on-chronic, malnutrition, encephalopathy, CKD staging) feed the same machinery, and documentation-integrity queries tend to get more insistent after a settlement like this, not less.

Worth raising: at the next group meeting, ask whether CDI query volume or wording changes are expected, and who signs off when a query asks you to confirm a diagnosis you don't think the chart supports.

B · The Debate

Is the No Surprises Act's arbitration system fixing underpayment, or inflating what everyone pays?

Georgetown researchers published an estimate on August 26 that independent dispute resolution has added $22.4 billion in costs over four years — $15.6B in awards above comparable in-network rates, $4.2B in administrative cost, $2.7B in filing fees — with $16.6B of it in 2025 alone, as providers filed 2.6 million disputes (up 77%). The anesthesiology, emergency medicine and radiology societies fired back in a joint statement the next day. Sitting underneath both: on August 13 the Fifth Circuit struck down the methodology insurers use to calculate the benchmark rate.

The case that IDR needs reining in

Jack Hoadley & Kennah Watts, Georgetown Center on Health Insurance Reforms (Health Affairs Forefront, Aug 26)

A law written to protect patients from surprise bills has quietly become a price-setting mechanism running above the market. Dispute volume and award size are both climbing far faster than anyone forecast, and the money doesn't disappear — it lands in premiums. Anticipating the objection that the benchmark is rigged low, the authors re-ran the analysis assuming fair rates were 150% and 200% of that benchmark; the 2025 excess only fell by $1.1B and $2.3B. The deeper problem is incentive: every award well above in-network rates makes staying in-network less attractive, which is the opposite of what the statute was for. Read the analysis

The case that IDR is working as written

American Society of Anesthesiologists, ACEP and American College of Radiology (joint statement, Aug 27)

The $22B figure isn't a measurement of excess, it's a measurement of the yardstick. The whole estimate rests on the qualifying payment amount — a median in-network rate that insurers calculate themselves — as if it were the correct price. "The evidence is overwhelmingly clear that QPAs are often inaccurate and unreasonably low," the societies wrote. A federal court agreed this month that insurers had been allowed to build the benchmark from factors that depress it. High provider win rates aren't proof of gaming; they're proof that opening offers were too low, in exactly the specialties patients can't shop for — the ones who see you because you arrived by ambulance. Read the statement

Where it might land: insurers must recalculate QPAs following the Fifth Circuit ruling, and federal enforcement discretion permitting the old methodology runs through at least October 1 — so the number both sides are arguing about is itself about to change. Hoadley's own concession is the interesting one: "Clearly it's an opportunity to rethink the QPA and decide if there's a better measure."

C · On My Radar

Employer health costs, 2027 — Business Group on Health members project a median 9.2% increase in medical spending next year (8% after benefit changes); WTW forecasts 11.1%, which would be the steepest in two decades. Healthcare Dive

Hospitals organizing to roll back the Medicaid cuts — STAT reports (Aug 27) that hospital lobbyists are laying groundwork to delay or soften the roughly $1 trillion in Medicaid reductions used to fund last year's tax bill. Long odds, but it shapes what your system budgets for. STAT

Plans and providers jointly oppose the state-directed payments rule — an unusual alliance: health plans and provider groups both urging rejection of the draft Medicaid SDP regulation, arguing it reaches beyond what the statute authorized. The rule would cap SDPs at 100% of Medicare in expansion states. Modern Healthcare

Respiratory picture (CDC, Aug 28) — acute respiratory illness driving care-seeking remains very low nationally, but COVID-19 activity is increasing both nationally and regionally, and rhinovirus/enterovirus is climbing. The composite stays calm while a component rises — same divergence as last week. CDC

Puerto Rico water emergency — CNN's Friday piece puts numbers to it: most of the archipelago in moderate-to-extreme drought affecting 3M+ people, 180,000+ AAA customers on rotating 48-hour shutoffs since Aug 7, ruptures in the 72-inch Superaqueduct feeding San Juan, ~65% of produced water lost to leaks, and forecasters warning of below-normal rainfall possibly into January. CNN

Cuba — the government confirmed the school year will open next week as scheduled despite shortages of uniforms and supplies, transport disruption and falling teacher numbers, against a backdrop of six nationwide grid collapses this year. Reuters via US News

Mets — lost 3-1 to Houston at Citi Field Friday, a third straight defeat and their longest skid since late July. Hunter Brown struck out 10 over 6⅔; Christian Scott walked five in 5⅓ and Varsho's two-run single off Lavender decided it. Carson Benge had the lone RBI double. Better news: Juan Soto took live BP and outfield reps and expects to return in September, likely at DH. Amazin' Avenue

Tropics — Tropical Storm Dolly formed Thursday and lost its closed circulation within about 24 hours; NHC dropped it Friday morning roughly 1,000 miles east of the Leewards. Remnant moisture may still bring heavy rain there this weekend. Nothing pointed at Florida. Local 10

Screens — Coyote vs. Acme went wide Friday at 96% on Rotten Tomatoes, the write-off-turned-rescue story of the year. Ridley Scott's The Dog Stars also opened, to more mixed notices. Streaming: The Whisper Man (De Niro, Adam Scott) landed on Netflix, and Dark Matter S2 is up on Apple TV+.

Golf tech — no new developments in the last 48 hours; 28th straight day. Pipeline unchanged: Shot Scope LM1, Garmin Approach G82 putting metrics, Par Breaker Swing Pulse.

D · Trends to Watch

"Last onset" is an estimate, not a fact. The cyclospora window has now been reported as closing on July 31, August 3, August 11 and August 15 across successive CDC revisions. On a six-week confirmation lag, a published end date is a statement about what's been confirmed, not about when exposure stopped — which means the clinical question stays open longer than the press release implies.

Payment fights have moved from the rate to the benchmark. QPA methodology in the courts, SDPs capped at "100% of Medicare," site-neutral tied to the physician-office rate — three separate disputes, one structure. Nobody is arguing about how much anymore; they're arguing about which number gets to be the reference point. Whoever controls the denominator wins without ever debating the payment.

Public health disputes are being fought over data and death certificates. The Pennsylvania measles exchange isn't about vaccine policy on its face — it's about who shares what with whom and how a death gets attributed. Documentation is becoming the contested surface, which puts clinicians in the middle of a fight they didn't pick.

Risk-adjustment enforcement has a template now. Self-disclosure, Chapter 11, half-billion settlement, acquirer insulated. The Villages sequence is clean enough that it will get copied — and it lands in the most Medicare Advantage–saturated market in the country, which is yours.

E · Ideas & Opportunities

One lab question, two minutes: does your GI multiplex panel report Cyclospora, and if not, what's the turnaround on modified acid-fast? Pair it with a pre-decided alternative for the sulfa-allergic patient so it isn't a 3 a.m. improvisation.

Read the pair back-to-back — the Georgetown Forefront piece and the ASA/ACEP/ACR rebuttal. Twenty minutes, and it's the clearest available primer on how hospital-based specialty pay actually gets set. Useful before any conversation about your group's payer contracts.

Post-nights watch: Coyote vs. Acme in theaters if you want the crowd-pleaser, The Whisper Man on Netflix if you want something to fall asleep angry at.